Mina Bissell, Curt Hines, and Irene Kuhn of the Biological Systems & Engineering Division led the development of the first clinically-relevant mouse model of human breast cancer to successfully express functional estrogen receptor positive adenocarcinomas. This model should be a powerful tool for testing therapies for aggressive ER+ breast cancers and for studying luminal cancers. Read more at the Berkeley Lab News Center.
Was this page useful?
Send
